Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...
Medpage Today on MSN9d
Patisiran Shows Long-Term Benefit in Hereditary ATTR With PolyneuropathyLong-term treatment with patisiran (Onpattro) led to modest changes for people with hereditary transthyretin amyloidosis ...
Emerging data suggest a possible genetic contributor to CIDP. In a recent study, patients with CIDP had a high frequency of perforin gene variations that impair the function of cytotoxic T and ...
AstraZeneca and Ionis are planning a US launch next month for Wainua, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR), after getting FDA ...
In the longest study of an RNAi therapeutic for any disease, patisiran treatment demonstrated modest improvements in patients ...
It is in P4 Extra that Ted Åström, 78, talks about his health problem. He entered the studio walking with a crutch and that's ...
Medpage Today on MSN9mon
Defining and Diagnosing Chronic Inflammatory Demyelinating PolyneuropathyChronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy. It affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback